CL2023002590A1 - Bloqueadores de kv1.3 - Google Patents

Bloqueadores de kv1.3

Info

Publication number
CL2023002590A1
CL2023002590A1 CL2023002590A CL2023002590A CL2023002590A1 CL 2023002590 A1 CL2023002590 A1 CL 2023002590A1 CL 2023002590 A CL2023002590 A CL 2023002590A CL 2023002590 A CL2023002590 A CL 2023002590A CL 2023002590 A1 CL2023002590 A1 CL 2023002590A1
Authority
CL
Chile
Prior art keywords
jammers
manufacturing
methods
present
polynucleotides encoding
Prior art date
Application number
CL2023002590A
Other languages
English (en)
Spanish (es)
Inventor
Fischer Munch Henrik
Original Assignee
Zealand Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zealand Pharma As filed Critical Zealand Pharma As
Publication of CL2023002590A1 publication Critical patent/CL2023002590A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2023002590A 2021-03-23 2023-08-31 Bloqueadores de kv1.3 CL2023002590A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21164384 2021-03-23
EP21213431 2021-12-09

Publications (1)

Publication Number Publication Date
CL2023002590A1 true CL2023002590A1 (es) 2024-03-15

Family

ID=80952156

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2023002590A CL2023002590A1 (es) 2021-03-23 2023-08-31 Bloqueadores de kv1.3

Country Status (12)

Country Link
US (1) US20240182531A1 (enExample)
EP (1) EP4314024A1 (enExample)
JP (1) JP2024511449A (enExample)
KR (1) KR20230159403A (enExample)
AU (1) AU2022245193A1 (enExample)
BR (1) BR112023019022A2 (enExample)
CA (1) CA3208713A1 (enExample)
CL (1) CL2023002590A1 (enExample)
IL (1) IL305219A (enExample)
MX (1) MX2023010930A (enExample)
TW (1) TW202304957A (enExample)
WO (1) WO2022200374A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4604984A1 (en) * 2022-10-18 2025-08-27 Zealand Pharma A/S Inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295838B6 (cs) 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
GB0414272D0 (en) 2004-06-25 2004-07-28 Cellpep Sa OsK1 derivatives
EP2474316B1 (en) 2004-10-07 2016-04-06 The Regents of The University of California Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels
US7833979B2 (en) 2005-04-22 2010-11-16 Amgen Inc. Toxin peptide therapeutic agents
PE20081140A1 (es) 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
US8429751B2 (en) 2009-03-13 2013-04-23 Trustwave Holdings, Inc. Method and apparatus for phishing and leeching vulnerability detection
NZ709913A (en) 2013-01-25 2019-05-31 Janssen Biotech Inc Kv1.3 antagonists and methods of use
JP2016527250A (ja) 2013-07-22 2016-09-08 キネタ ワン リミテッド ライアビリティ カンパニーＫｉｎｅｔａ Ｏｎｅ，Ｌｌｃ 毒素系治療用ペプチド及びその医薬組成物の眼科的使用
US20180264080A1 (en) 2015-01-09 2018-09-20 Kineta One, Llc TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION
EP4031162A1 (en) * 2019-09-20 2022-07-27 Zealand Pharma A/S Kv1.3 blockers

Also Published As

Publication number Publication date
US20240182531A1 (en) 2024-06-06
CA3208713A1 (en) 2022-09-29
EP4314024A1 (en) 2024-02-07
JP2024511449A (ja) 2024-03-13
AU2022245193A1 (en) 2023-09-07
IL305219A (en) 2023-10-01
BR112023019022A2 (pt) 2023-10-17
WO2022200374A1 (en) 2022-09-29
KR20230159403A (ko) 2023-11-21
TW202304957A (zh) 2023-02-01
MX2023010930A (es) 2023-09-28

Similar Documents

Publication Publication Date Title
CL2022000660A1 (es) Un bloqueador de canales iónicos que comprenden el componente inhibidor kv1.3
ES3063862T3 (en) Method and device for channel and interference measurement
MX2022007576A (es) Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
CL2021001690S1 (es) Estuche para audífonos.
CL2021000384S1 (es) Banda tipo pulsera para un dispositivo.
UY37554A (es) (aza)indol- y benzofuran-3-sulfonamidas
CL2020000594S1 (es) Estuche de auriculares.
MX2022007841A (es) Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos.
CL2019002317A1 (es) Método y equipo de usuario para transmitir preámbulo de acceso aleatorio, y método y estación base para recibir preámbulo de acceso aleatorio.
CL2021001175S1 (es) Estuche para audífonos.
MX2020013630A (es) Analogos de rapamicina y usos de los mismos.
ECSP21053104A (es) Moduladores de la expresión de hsd17b13
CO2018005393A2 (es) Anticuerpos anti-htra1 y métodos de uso de los mismos
CR20170392A (es) Compuestos bicíclicos de sulfonamida cetona
CL2021000385S1 (es) Banda tipo pulsera para un dispositivo.
AR109761A1 (es) Determinación de desplazamiento del esquema de modulación y codificación de información de control en la información de control de enlace ascendente por el canal físico compartido de enlace ascendente con intervalo de tiempo abreviado
AR120883A1 (es) Anticuerpos anti-fgfr2b
AR120886A1 (es) Anticuerpos anti-fgfr2b
CL2021000232S1 (es) Parte de afeitadora.
MX2023004366A (es) Composiciones para el tratamiento de la hipertension.
BR112018075413A2 (pt) dispositivo e método para produzir e método para produzir um revestimento funcional estampado para uma camada de vidro
BR112018068016A2 (pt) técnica para aumentar a taxa de transferência para vinculação de canal
PE20210109A1 (es) Moduladores de la expresion de irf4
MY195784A (en) New Diphosphites Based on Cis-Butene-1,4-Diol
MX2019008682A (es) Moduladores del canal de potasio.